| Sheetal Agarwal Narahari, PAC | |
|
2285 Sequoia Dr, Aurora, IL 60506-6209 | |
| (630) 859-6700 | |
| Not Available |
| Full Name | Sheetal Agarwal Narahari |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 24 Years |
| Location | 2285 Sequoia Dr, Aurora, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720037823 | NPI | - | NPPES |
| 629748000 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 9553 (Minnesota) | Secondary |
| 363A00000X | Physician Assistant | 085002950 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocate Health And Hospitals Corporation | 7810800935 | 2422 |
News Archive
A recent United States Army study found that excessive bone growth, also known as heterotopic ossificiation (HO), affects up to 70 percent of soldiers who are severely wounded during combat. A much smaller percentage of the civilian population also suffers from HO following trauma or invasive surgery. The excessive bone forms within muscles and other tissues causing severe pain, reduced mobility and even local paralysis if untreated.
An Indiana University study has revealed that there may be a greater connection between mussels and muscles than previously thought.
Several newly identified markers could provide valuable insight to predict the risk of rupture abdominal aortic aneurysms (AAA), according to new research published in the October issue of the Journal of Nuclear Medicine.
Twice-yearly intravenous infusion with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer. The report from an international research study, the first to document reduced fracture risk in men receiving the hormone-blocking treatment, was published today in the print edition of the New England Journal of Medicine (NEJM). Both fundamental research on rank ligand (RANKL) in prostate cancer bone metastasis and other molecular factors involved in the denosumab study were supported at Massachusetts General Hospital with funding from the Prostate Cancer Foundation (PCF).
The prevalence of left-sided advanced colorectal neoplasms was lower in participants in a community setting, but not right-sided advanced neoplams, who had received a colonoscopy in the preceding 10 years, according to a new study published online December 30 in the Journal of the National Cancer Institute.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sheetal Agarwal Narahari, PAC 2357 Sequoia Dr, Aurora, IL 60506-6222 Ph: (630) 859-6800 | Sheetal Agarwal Narahari, PAC 2285 Sequoia Dr, Aurora, IL 60506-6209 Ph: (630) 859-6700 |
News Archive
A recent United States Army study found that excessive bone growth, also known as heterotopic ossificiation (HO), affects up to 70 percent of soldiers who are severely wounded during combat. A much smaller percentage of the civilian population also suffers from HO following trauma or invasive surgery. The excessive bone forms within muscles and other tissues causing severe pain, reduced mobility and even local paralysis if untreated.
An Indiana University study has revealed that there may be a greater connection between mussels and muscles than previously thought.
Several newly identified markers could provide valuable insight to predict the risk of rupture abdominal aortic aneurysms (AAA), according to new research published in the October issue of the Journal of Nuclear Medicine.
Twice-yearly intravenous infusion with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer. The report from an international research study, the first to document reduced fracture risk in men receiving the hormone-blocking treatment, was published today in the print edition of the New England Journal of Medicine (NEJM). Both fundamental research on rank ligand (RANKL) in prostate cancer bone metastasis and other molecular factors involved in the denosumab study were supported at Massachusetts General Hospital with funding from the Prostate Cancer Foundation (PCF).
The prevalence of left-sided advanced colorectal neoplasms was lower in participants in a community setting, but not right-sided advanced neoplams, who had received a colonoscopy in the preceding 10 years, according to a new study published online December 30 in the Journal of the National Cancer Institute.
› Verified 9 days ago
Wajahat Khan, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1325 N Highland Ave, Aurora, IL 60506 Phone: 630-801-2633 | |
Bao Ling Pauline Soh, Physician Assistant Medicare: Medicare Enrolled Practice Location: 75 Executive Dr Ste 447, Aurora, IL 60504 Phone: 312-973-2554 | |
Amanda Lynn Roche, PHYSICIAN ASSISTANT Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 270 N Kingsway Dr, Aurora, IL 60506 Phone: 630-849-4670 | |
Isabella Elaine Liu, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1221 N Highland Ave, Aurora, IL 60506 Phone: 630-264-8720 Fax: 630-264-8423 | |
Leah Kristene Michelli, MMS, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 3965 75th St, Suite 103, Aurora, IL 60504 Phone: 630-375-1625 | |
Mrs. Sara J Bealert, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 4100 Healthway Dr, Aurora, IL 60504 Phone: 630-851-3105 | |
Miss Erin Kathryn Lindeman, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2040 Ogden Ave Ste 304, Aurora, IL 60504 Phone: 630-898-3727 Fax: 630-499-2430 |